Cancer research has revealed that KCNJ15, as a differentially expressed gene, correlates with the clinical prognosis of renal cancer, esophageal squamous cell carcinoma, breast cancer, and glioma (Table 1). This evidence concerns the gene KCNJ15 and esophageal squamous cell carcinoma.